Back to search
FDAFDA · Food and drugs·Recall number D-0575-2025

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Published August 20, 2025 · Recall initiated: July 29, 2025

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
LEVOXYL
Manufacturer
Pfizer
Distributor
Within U.S
UPC
0360793856018
Lot
Lot #: 24C11, Exp 2/28/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card